Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases

Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases

US Patent 6894038 · Granted May 17, 2005

Estimated economic value: $3,076,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pro-drug forming compounds2019
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017
Imidazolyl progesterone antagonists2015
Mesoprogestins (progesterone receptor modulators) for the treatment and preventi2012
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroi2010
Mesoprogrestins (progesterone receptor modulations) as a component of compositio2009
Progesterone receptor modulators with increased antigonadotropic activity for fe2009
Estradiol prodrugs2009
Compounds with sulphonamide group and pharmaceutical compositions containing the2009
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroi2008
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid2008